Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.

Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.

A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.

Wade Iams, MD, MSCI, assistant professor of Medicine, is the recipient of a National Comprehensive Cancer Network Foundation Young Investigator Award.

People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.

David Cortez, PhD, has been named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center (VICC).

More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.